| Literature DB >> 35352437 |
Àngels Camins1,2, Pablo Naval-Baudin1, Carles Majós1, Joanna Sierpowska3,4,5,6, Jose L Sanmillan7, Mónica Cos1, Antoni Rodriguez-Fornells5,6,8, Andreu Gabarrós7.
Abstract
BACKGROUND ANDEntities:
Keywords: diffusion tensor imaging; glioma; inferior fronto-occipital fasciculus; surgical navigation systems; temporal lobe
Mesh:
Year: 2022 PMID: 35352437 PMCID: PMC9544573 DOI: 10.1111/jon.12992
Source DB: PubMed Journal: J Neuroimaging ISSN: 1051-2284 Impact factor: 2.324
FIGURE 1(A) The inferior fronto‐occipital fascicle (IFOF) is represented in green on the color maps and is shown in the axial plane at the level of the subinsular region (orange triangles). (B) Tracking of the IFOF is performed with two regions of interest (ROIs) drawn on coronal slices perpendicular to the IFOF trajectory. In general, the seed ROI is placed in the deep white matter of the occipital lobe and the target ROI at the anterior edge of the genu of corpus callosum. (C) After connecting the two ROIs, the tractogram is inspected for a priori anatomical consistency. The exact location of the ROI may vary depending on the displacement of the tract, which may be inspected on the fractional anisotropy color map
FIGURE 2Proposed patterns of tract involvement. Type 1: Displacement pattern with preserved or increased fractional anisotropy (FA) and tonality. Type 2: Infiltration‐edema pattern with reduced FA and tonality both with and without displacement. Type 3: Destruction pattern when tonality cannot be detected (orange triangles: inferior fronto‐occipital fascicle; circle: tumor)
Patients included in the study
| Sex | Age (years) | Histology | Grade | Location | Insular involvement | Tract pattern | Displacement direction | |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 22 | GG | 1 | L | Yes | 1 | Med |
| 2 | F | 49 | PXA | 2 | L | No | 0 | None |
| 3 | F | 63 | DA | 2 | M | Yes | 2 | None |
| 4 | M | 33 | DA | 2 | M | Yes | 1 | Med‐Inf |
| 5 | M | 25 | DA | 2 | M | Yes | 2 | Med‐Sup |
| 6 | M | 31 | DA | 2 | LM | Yes | 2 | Med‐Sup |
| 7 | F | 45 | AA | 3 | L | No | 2 | Med |
| 8 | M | 52 | AA | 3 | LM | Yes | 1 | Sup |
| 9 | M | 41 | AA | 3 | M | Yes | 3 | Med |
| 10 | F | 42 | AA | 3 | M | Yes | 2 | Med‐Sup |
| 11 | M | 32 | AO | 3 | M | No | 2 | Lat‐Sup |
| 12 | F | 55 | AA | 3 | LM | Yes | 2 | Inf |
| 13 | M | 46 | AA | 3 | L | Yes | 2 | Med‐Sup |
| 14 | M | 58 | AA | 3 | L | No | 2 | Med‐Sup |
| 15 | F | 41 | AA | 3 | M | No | 2 | Lat‐Sup |
| 16 | F | 46 | OA | 3 | M | Yes | 2 | Lat‐Sup |
| 17 | F | 39 | OA | 3 | LM | Yes | 2 | Med‐Sup |
| 18 | M | 36 | OA | 3 | M | Yes | 3 | Med‐Sup |
| 19 | M | 38 | OA | 3 | LM | Yes | 2 | Med‐Sup |
| 20 | F | 34 | AA | 3 | M | Yes | 3 | Med‐Sup |
| 21 | M | 71 | GBM | 4 | M | No | 1 | Sup |
| 22 | F | 64 | GBM | 4 | L | No | 1 | Med |
| 23 | F | 41 | GBM | 4 | M | Yes | 3 | Med‐Sup |
| 24 | M | 58 | GSM | 4 | L | No | 2 | Med |
| 25 | M | 59 | GBM | 4 | L | Yes | 2 | Med‐Sup |
| 26 | F | 69 | GBM | 4 | L | Yes | 2 | Med‐Sup |
| 27 | F | 49 | GBM | 4 | L | No | 3 | Med‐Sup |
| 28 | M | 64 | GBM | 4 | M | No | 2 | Lat‐Sup |
| 29 | F | 66 | GBM | 4 | L | Yes | 3 | Med‐Inf |
| 30 | F | 62 | GSM | 4 | L | Yes | 2 | Med‐Inf |
| 31 | F | 56 | GBM | 4 | M | No | 2 | Lat‐Sup |
| 32 | F | 57 | GBM | 4 | L | No | 2 | Med‐Sup |
| 33 | M | 62 | GBM | 4 | L | Yes | 2 | Sup |
| 34 | F | 39 | GBM | 4 | LM | Yes | 3 | Med‐Sup |
Abbreviations: AA, anaplastic astrocytoma; DA, diffuse astrocytoma; F, female; G, ganglioglioma; GBM, glioblastoma; GSM, gliosarcoma; Inf, inferior; L, lateral; Lat, lateral; LM, lateromedial; M, male; Med, medial; OA, anaplastic oligodendroglioma; PXA, pleomorphic xanthoastrocytoma; Sup, superior.
Tract pattern: 1 = Displaced, 2 = Edematous/infiltrated, 3 = Destroyed.
Pattern of tract involvement by tumor grade, intratemporal location, and presence of insular involvement
|
| None ( | Type 1 (Displaced) ( | Type 2 (Edema/infiltration) ( | Type 3 (Destroyed) ( |
| |
|---|---|---|---|---|---|---|
| By tumor grade | ||||||
| Grade 1 ( | 1 | – | 1 (100%) | – | – | .23 |
| Grade 2 ( | 5 | 1 (20%) | 1 (20%) | 3 (60%) | – | |
| Grade 3 ( | 14 | – | 1 (7%) | 10 (71%) | 3 (21%) | |
| Grade 4 ( | 14 | – | 2 (14%) | 8 (57%) | 4 (29%) | |
| By intratemporal location | ||||||
| Medial | 14 | – | 2 (14 %) | 8 (57%) | 4 (29%) | .77 |
| Lateral | 14 | 1 (7%) | 2 (14 %) | 9 (64%) | 2 (14 %) | |
| Lateromedial | 5 | – | 1 (20%) | 4 (60%) | 1 (20%) | |
| By insular involvement | ||||||
| With insula | 22 | 3 (14%) | 13 (59%) | 6 (27%) | .38 | |
| No insula | 12 | 1 (8%) | 2 (17%) | 8 (67%) | 1 (8%) | |
Note: Significance statistics are generated using Fisher's Exact Test.
Abbreviation: n, number of subjects.
FIGURE 3Patterns of tract displacement depending on main location of the tumor in the temporal lobe. Above (A‐C) examples of medial location (A), lateral‐medial location lesion (B), and lateral location lesions (C); 2‐dimensional bilateral inferior frontal occipital fascicle trajectory on this slice is marked in orange. Below (D‐F), circular plots representing the main vector of displacement for tumors each group. In blue, a representation of coronal view of insula and temporal lobe. In orange spikes, a representation of the lesion location. Arrows represent count vectors of cases that presented this direction of displacement among all the tumors in this location. Note that one medial and one lateral tumors were excluded from this graph as there was no displacement. Three‐way comparison between the groups with Watson‐Williams test yielded p = .044. n, number of subjects
FIGURE 4Patterns of tract displacement for subgroups of medial located tumors depending on if they had insular involvement or not. Above (A and B) examples of medial tumors without insular involvement (A) and medial tumors with insular involvement (B); 2‐dimensional bilateral inferior frontal occipital fascicle trajectory on this slice is marked in orange. Below (C and D), circular plots representing the main vector of displacement for tumors in each subgroup. Comparison between the two groups with Watson's two sample test yielded p between .01 and .05. n, number of subjects
Quantitative tract characteristics between tract‐involvement types ipsilateral to lesion
| Type 1 | Type 2 | Type 3 |
| |
|---|---|---|---|---|
|
| 5 | 21 | 5 | |
| Whole tract volume (mm2) | 6310 ± 3528 | 5308 ± 4447 | – | .408 |
| Whole tract mean FA | 0.46 ± 0.03 | 0.39 ± 0.06 | – | <.01 |
| ROI mean FA | 0.42 ± 0.06 | 0.32 ± 0.07 | 0.29 ± 0.09 | .035 |
Note: Values presented as mean ± standard deviation. Whole tract values are not obtainable for type 3 involvement, because the tract cannot be reconstructed. Whole tract volume and whole tract mean FA between types 1 and 2 were compared by Wilcoxon rank‐sum test. ROI mean FA between the three groups was compared using Kruskal‐Wallis test. Comparison for ROI mean FA between types 1 and 2 with Wilcoxon rank‐sum test yields p = .017 and between types 2 and 3 yields p = .629.
Abbreviations: FA, fractional anisotropy; n, number of subjects; ROI, region of interest.
Comparison of quantitative tract characteristics between lesional and contralateral sides for each tract involvement type
| Ipsilateral | Contralateral |
| |
|---|---|---|---|
| Type 1 ( | 5 | 5 | |
| Whole tract volume (mm2) | 6310 ± 3528 | 6669 ± 5327 | 1 |
| Whole tract mean FA | 0.46 ± 0.03 | 0.47 ± 0.03 | .813 |
| ROI mean FA | 0.42 ± 0.06 | 0.39 ± 0.08 | .625 |
| Type 2 ( | 21 | 21 | |
| Whole tract volume (mm2) | 5308 ± 4447 | 9084 ± 5938 | .004 |
| Whole tract mean FA | 0.39 ± 0.06 | 0.48 ± 0.04 | <.001 |
| ROI mean FA | 0.32 ± 0.07 | 0.41 ± 0.06 | <.001 |
| Type 3 ( | 5 | 5 | |
| ROI mean FA | 0.29 ± 0.09 | 0.4 ± 0.06 | .063 |
Note: Values presented as mean ± standard deviation. Whole tract values are not obtainable for type 3 involvement, because by definition the tract cannot be reconstructed. Variables were compared by Wilcoxon rank‐sum test.
Abbreviations: FA, fractional anisotropy; n, number of subjects; ROI, region of interest.